Cuorips Inc.

Cuorips provides the research, development, manufacture, commercialization, and sale of human iPS cell-derived cardiomyocyte sheets. The company offers cellular and tissue-based, and cell processing products, as well as contract development and manufacturing, and consulting services. Incorporated in 2017 and headquartered in Tokyo, Japan, Cuorips was formerly known as Cuore Inc. before rebranding in June 2017.